Appeal letter sample: Adalimumab for UC
Template letter for professionals to complete so patients with ulcerative colitis (UC) may receive authorization to take adalimumab when they are no longer responsive to infliximab. Healthcare provider completes letter and patient submits to their insurance company.
For further information, call CCFA at our IBD Help Center: 888.MY.GUT.PAIN (888.694.8872).
The Crohn's & Colitis Foundation of America provides information for educational purposes only. We encourage you to review this educational material with your health care professional. The Foundation does not provide medical or other health care opinions or services. The inclusion of another organization's resources or referral to another organization does not represent an endorsement of a particular individual, group, company or product.
About this resource
Published: May 1, 2012
Adalimumab for UC (.doc)
File: 34 KB